Regulatory Aspects of Pharmaceuticals’ Exports in Gulf Cooperation Council Countries
1, 2, 2, 2, 2, 3, 3, 2★, 2★ Corresponding author
- 1Department of Advanced Pharmaceutical Studies, Manipal University, Manipal, INDIA.
- 2Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, INDIA.
- 3Zydus Research Center, Ahmedabad, INDIA.
CORRESPONDENCE
Musmade PB
Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, INDIA.
Volume 3, Issue 2 · pp. 155-162 · 2011 · DOI: 10.4103/0975-1483.80305
ABSTRACT
The Gulf cooperation council (GCC) region is considered as “Emerging market” for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slowdown in highly well-off and regulated market of the EU and US, raised the demand for alternate destinations for business. The regulations of Gulf countries are encouraging the import of quality generic products, which can be good news to the Indian drug manufacturers.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
S, P., MD, J., PB, D., VS, L., KB, T., T, K., Y, K., PB, M., & N, U. (2011). Regulatory Aspects of Pharmaceuticals’ Exports in Gulf Cooperation Council Countries. Journal of Young Pharmacists, 3(2), 155-162. https://doi.org/10.4103/0975-1483.80305
Copyright and licence
© 2011 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
